Key points
- Daily cannabis use is very different from occasional use.
- Repeated THC exposure may gradually shift the brain into a different operating state.
- Feeling “normal” after cannabis may mean return to an adapted brain state, not the brain’s original baseline.
- The brain learns what it repeats. The same neuroplasticity underlying addiction also makes recovery possible.
I’ve heard countless times that “Cannabis doesn’t really get me high anymore. I just use it to feel normal.” For years, I thought the answer was straightforward: tolerance to the drug. That’s also true—but it is an incomplete answer
A fascinating new study by Katharina Lege and colleagues at Maastricht University will be published on July 15th. It suggests something else may be happening. Tolerance does not mean the brain has recovered. It means the brain has adapted to cannabis
Rather than examining individual brain regions, the investigators studied how THC changes the brain’s dynamic brain states—the constantly shifting patterns of communication among large-scale brain networks. They found not only acute changes after THC exposure, but also persistent neuroadaptations in chronic users. Together, these findings raise an intriguing possibility: repeated cannabis use may gradually produce an adapted new normal operating brain state. This adaptive “Brain on THC” is not simply repeated episodes of intoxication.
The Brain Is Always Changing
Lege’s new study examined how THC affects these dynamic brain states in both occasional and chronic cannabis users. Using a double-blind, placebo-controlled design, they found that THC use reduced the brain’s ability to enter one highly integrated state associated with efficient communication across multiple brain networks. Participants also performed worse on tests of sustained attention, particularly occasional users
These findings fit decades of <a href="https://healthylife7.com/healthcares-digital-skills-gap-has-a-measurement-problem-and-new-research-is-pushing-for-a-fix/” title=”Healthcare's digital skills gap has a measurement problem, and new research is pushing for a fix”>research showing that acute cannabis impairs attention, working memory, executive function, psychomotor performance, and judgment, even when users appear outwardly functional
But the more novel and important finding involved chronic users. Although daily users reported feeling less intoxicated after THC—a familiar sign of tolerance—the investigators also found their brains already differed before receiving the drug. Chronic users were not simply less intoxicated; their brains had already undergone measurable neuroadaptation to daily use of the drug
Tolerance Means Adaptation
Lege also reported that both the immediate effects of THC and the persistent changes seen in chronic users closely tracked the brain’s own natural cannabinoid receptor(CB1) distribution, through which THC acts. Chronic THC causes the brain’s endocannabinoid system to adapt, reducing endogenous CB1 receptor availability, with gradual recovery after abstinence. Withdrawal symptoms—including irritability, anxiety, insomnia, reduced appetite, and craving—provide additional evidence that the brain has produced a “new normal” in response to repeated THC exposure.
Traditionally, cannabis intoxication has been viewed as an episodic event: use cannabis, become intoxicated, then return to baseline. The newer neuroscience suggests another possibility for daily cannabis users: the brain’s normal baseline has been altered. The question becomes, “What happens when someone gets high?” but also, “What happens when the brain adapts to being high every day?”
A Different Way to Think About Daily Cannabis Use
Rather than producing isolated effects on individual receptors or circuits, repeated THC exposure appears to induce coordinated neuroplastic changes across multiple interacting brain systems to produce an adapted-to-THC brain operating state. Continued cannabis use temporarily maintains that state, while abstinence unmasks the neurobiological adaptations that developed during chronic exposure
Why do so many daily cannabis users say they no longer use cannabis to become intoxicated but simply to feel “normal?” They are maintaining the neuroadapted state their brain has gradually learned to expect. They are not restoring their original brain function
Feeling normal is not necessarily the same as functioning as you did before regular cannabis use. Daily users may feel normal because their brains have recalibrated their internal baselines. Recovery, then, is not simply eliminating THC—it is allowing the brain to establish a new, drug-free equilibrium through recovery-related neuroplasticity
The Brain Learns What it Repeats
One of the brain’s greatest strengths is its remarkable ability to learn from repeated experience-practice makes neural circuits more efficient. Practice strengthens the neural circuits that are used most often. The same principle applies to repeated cannabis use. Each episode of THC exposure reinforces neural pathways that link cannabis with relief, reward, or routine. Over months or years of daily use, cannabis may gradually become the brain’s default response to stress, boredom, anxiety, sleeplessness, or emotional discomfort. What begins as a conscious choice becomes an increasingly automatic learned response.
Cannabis Essential Reads
Early Cannabis Use Linked to Memory Slowdown in Teens
The Sober Curious Movement’s Big Blind Spot
From the brain’s perspective, this is simply efficient learning. Eventually, the adapted brain comes to expect THC as part of its normal operating environment. Feeling “normal” without cannabis may then require another round of neuroplasticity as the brain relearns how to regulate mood, sleep, motivation, and reward on its own
Repeated cannabis use also teaches the brain associations that may not be adaptive. If THC is repeatedly paired with falling asleep, managing stress, socializing, or having sex, those normal activities may gradually become linked to the drug itself. Over time, the brain may begin to expect THC before these experiences feel natural or rewarding. What began as a learned association eventually becomes an expectation, reinforcing continued cannabis use
A New Framework
The Lege study does not demonstrate that daily cannabis use creates a distinct brain state. It does show that THC perturbs dynamic brain states, that chronic users exhibit persistent neuroadaptations even before receiving THC, and that both the acute and persistent changes observed with daily use closely follow the brain’s CB1 receptor distribution. Together with decades of research on tolerance, withdrawal, and CB1 receptor regulation, these findings support an intriguing—but still unproven—clinical hypothesis: repeated THC exposure gradually shifts the brain toward an adapted cannabis operating state, one that differs fundamentally from the transient effects experienced by occasional users.
Evolution designed the brain to adapt because adaptation usually improves survival. The brain is not malfunctioning when it adapts to repeated THC exposure. It is doing exactly what healthy brains evolved to do—modify their function in response to repeated experience. The problem is that this remarkable capacity for adaptation becomes organized around a powerful pharmacologic reward rather than the natural rewards that normally shape motivation, learning, decision-making, and behavior
This chronic cannabis framework is conceptually similar to the one I have used to understand opioid use disorder (OUD). In both conditions, repeated drug exposure stimulates endogenous receptor systems and elicits compensatory neuroadaptations that help maintain function in the continued presence of the drug. Those adaptations ultimately shift the brain toward a new operating state
Repeated drug use temporarily maintains that tenuous adapted state, whereas abstinence reveals—quite dramatically in OUD—the underlying neurobiological changes. The important differences lie in the magnitude, clinical manifestations, and risks of the two disorders—not necessarily in the fundamental principle of neuroadaptation
If this emerging framework continues to be supported, addiction may be understood as a unique chronic brain state and not simply repeated single intoxications. That shift is necessary to change how we think about prevention, preaddiction, treatment, and recovery by focusing greater attention on preserving or restoring healthy brain function through recovery-related neuroplasticity rather than simply eliminating the drug
The next question is equally important. If the brain can learn to depend on THC, how does it relearn to function without it? That question—and the science of recovery-related neuroplasticity—is the subject of the next article in this series
Lege KS, Mallaroni P, Mortaheb S, Mason NL, Theunissen EL, Tse DHY, Toennes SW, Demertzi A, Ramaekers JG. Cannabis Perturbs Dynamic Brain States. Biol Psychiatry. 2026 Jul 15;100(2):219-229. doi: 10.1016/j.biopsych.2025.10.015. Epub 2025 Oct 21. PMID: 41130555
Ramaekers JG, Mason NL, Toennes SW, Theunissen EL, Amico E. Functional brain connectomes reflect acute and chronic cannabis use. Sci Rep. 2022 Feb 14;12(1):2449. doi: 10.1038/s41598-022-06509-9. PMID: 35165360; PMCID: PMC8844352
Patrick ME. Daily or near-daily cannabis and alcohol use by adults in the United States: A comparison across age groups. Addiction. 2025 Apr;120(4):779-782. doi: 10.1111/add.16748. Epub 2024 Dec 23. PMID: 39711180; PMCID: PMC11907322
Karunakaran KD, Pascale M, Ozana N, Potter K, Pachas GN, Evins AE, Gilman JM. Intoxication due to Δ9-tetrahydrocannabinol is characterized by disrupted prefrontal cortex activity. Neuropsychopharmacology. 2024 Aug;49(9):1481-1490. doi: 10.1038/s41386-024-01876-5. Epub 2024 May 7. PMID: 38714786; PMCID: PMC11251178
Anderson Z, Gunn M, Jones E, Ajilore O, Phan KL, de Wit H, Klumpp H, Calhoun V, Crane NA. Δ9-Tetrahydrocannabinol Alters Limbic and Frontal Functional Brain Connectomes Among Young Adult Cannabis Users. Biol Psychiatry Cogn Neurosci Neuroimaging. 2026 May;11(5):580-589. doi: 10.1016/j.bpsc.2025.09.005. Epub 2025 Sep 14. PMID: 40957507; PMCID: PMC13180306
Baacke KA, Sullivan RM, Shankula CA, Lisdahl KM. Network topology and cannabis use following two weeks of monitored abstinence: moderation of sex and patterns of use findings. Front Adolesc Med. 2025;3:1549771. doi: 10.3389/fradm.2025.1549771. Epub 2025 Mar 25. PMID: 41822540; PMCID: PMC12978186
Lege KS, Mallaroni P, Mortaheb S, et al. Cannabis perturbs dynamic brain states. Biol Psychiatry. 2026;100(2):219-229. doi:10.1016/j.biopsych.2025.10.015
Gilman JM, Janes AC. Dynamic brain states with cannabis intoxication: beyond “more is better” in interpreting brain connectivity. Biol Psychiatry. 2026;100(2):129-131. doi:10.1016/j.biopsych.2026.05.005
Gowin JL, Sloan ME, Stangl BL, et al. Brain function outcomes of recent and lifetime cannabis use. JAMA Netw Open. 2025;8(1):e2457069. doi:10.1001/jamanetworkopen.2024.57069
Burdinski DCL, Gilman JM, Evins AE, et al. Year-long cannabis use for medical symptoms and brain activation during cognitive processes. JAMA Netw Open. 2024;7(9):e2436035. doi:10.1001/jamanetworkopen.2024.36035
McDonald AJ, Schuster RM, Moreno MA, et al. Cannabis use and misuse following recreational cannabis legalization. JAMA Netw Open. 2025;8(4):e256551. doi:10.1001/jamanetworkopen.2025.6551
Caulkins JP. Changes in self-reported cannabis use in the United States from 1979 to 2022. Addiction. 2024;119(9):1648-1652. doi:10.1111/add.16519
Jeffers AM, Glantz S, Byers AL, Keyhani S. Association of cannabis use with cardiovascular outcomes among US adults. J Am Heart Assoc. 2024;13(5):e030178. doi:10.1161/JAHA.123.030178
Austin-Zimmerman I, Colizzi M, Di Forti M, et al. The impact of schizophrenia genetic load and heavy cannabis use on the risk of psychotic disorder. Psychol Med. 2025;55:e15. doi:10.1017/S0033291724003072
Young-Wolff KC, Adams SR, Vinson Y, et al. Adolescent cannabis use and risk of psychotic, bipolar, depressive, and anxiety disorders. JAMA Health Forum. 2026;7(2):e255136. doi:10.1001/jamahealthforum.2025.5136
Bedillion MF, Cooper ZD, Haney M. Pharmacotherapy for cannabis use disorder: preclinical and clinical progress. Neuropsychopharmacology. 2026. doi:10.1038/s41386-026-02131-2
Hill KP, Gold MS. Developmental Timing, Substance Exposure, and Persistent Brain Change: Recontextualizing Cannabis, Stimulants, and Opioids Across an Extended Neurodevelopmental Window. Am J Psychiatry. 2026 Apr 1;183(4):226-228. doi: 10.1176/appi.ajp.20260052. Epub 2026 Apr 1. PMID: 41917710
Hsu M, Shah A, Jordan A, Gold MS, Hill KP. Therapeutic Use of Cannabis and Cannabinoids: A Review. JAMA. 2026 Jan 27;335(4):345-359. doi: 10.1001/jama.2025.19433. PMID: 41296368
